ELIZABETH KOLICH: Open Payments
NPI 1447946587 · APOPKA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$770 in 27 payments from 9 companies in 2025. Trend: 2023 $333 · 2024 $800 · 2025 $770
Food & beverage: $770
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 8 | $392 |
| ABBVIE INC. | 4 | $93 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $92 |
| Janssen Biotech, Inc. | 3 | $63 |
| Galderma Laboratories, L.P. | 3 | $56 |
| E.R. Squibb & Sons, L.L.C. | 1 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
| Botanix SB Inc | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
Products named: OTEZLA, SKYRIZI, TREMFYA, NEMLUVIO, Sotyktu, SOFDRA, EBGLYSS.
Industry payments across FL — which companies pay providers there.
